S&P 500 Moderna Rebound: Can Biotech Strength Cushion the AI Chip Sell-Off?
Crypto Daily
STARTS NOW! Rebel's Edge 1pm $NVDA $PANW $MRNA $GRMN 🏈 NAJARIAN SPORTS 🏴☠️ with @petenajarian NCAA: who dominated the portal what schools really dominated the portal, Pete's Top 3 NFL: Free Agency is less than a month Top 5 QBs and possible landing spots #ITSNOTANOPTION 📙 https://t.co/pdCmmm2onX
@MarketRebels
Moderna got the FDA to change its mind and review its flu vaccine after some concessions
MarketWatch
*FDA REFUSES TO REVIEW MODERNA'S APPLICATION FOR EXPERIMENTAL FLU SHOT
$MRNA https://t.co/fcVprJEa0W
@Investingcom
📅IT’S A BIG WEEK OF EARNINGS!
📈 $CSCO $ANET $AMAT $NBIS $HOOD $COIN $DKNG $SHOP $APP $ALAB $DDOG $NET $HUBS $PINS $SPOT $KO $KHC $MCD $WEN $CVS $MRNA $OSCR $F $RIVN $RACE $LYFT $TMUS $BP WILL DELIVER RESULTS!
💰MAKE SMARTER INVESTMENT DECISIONS WITH ‘PRO PICKS AI’: https://t.co/o9NLlYA1jt
@Investingcom
Moderna and Merck stocks jump on positive cancer vaccine results.
$MRNA +11.81%
$MRK +1.75% https://t.co/foSt2643jH
@YahooFinance
Moderna gains on report it held talks with at least one large drugmaker
SeekingAlpha
Pfizer, Moderna shares fall on report that Trump officials will link child deaths to Covid shots
CNBC
Moderna cuts high end of 2025 revenue outlook on vaccine shipment delay in U.K. - CNBC
CNBC
More than 800 Moderna employees will lose their jobs this year as costs are slashed
MarketWatch
Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shot - CNBC
CNBC
FDA approves new Moderna COVID-19 vaccine - Axios
Axios
*VACCINE STOCKS TANK, MODERNA $MRNA CRATERS AFTER FDA BIOLOGICS HEAD ABRUPTLY STEPS DOWN https://t.co/V0qHNfFxAU
@Investingcom
Bloomberg reports Trump is considering pulling funding for Moderna's bird flu vaccine
Forexlive
Moderna looks to pipeline to restore battered stock after quarterly loss
MarketWatch
US awards Moderna $590 million for bird flu vaccine development - Reuters
Reuters
STARTS NOW! Rebel's Edge 🏴☠️ 1pm Line up: World on fire 🔥 #OIL STOCKS $ITCI $SAGE $MRNA $ANF SPORTS @petenajarian 🏈#NFL: Wild Card Teams that run the ball, move on in the playoffs. NCAA: Football Year 1 12 team playoff, Monster success, down the 2 https://t.co/GmUwLlNsmQ
*PALANTIR, MICROSTRATEGY SET TO JOIN NASDAQ 100 AS OF DEC. 23, REPLACING MODERNA, SUPER MICRO COMPUTER
$PLTR $MSTR $MRNA $SMCI https://t.co/RKIfmAfbU7
@Investingcom
Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS
MarketWatch
Moderna said Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years and older, making it the country's first authorized mRNA-based shot for the condition https://t.co/iF9NrxP9t2 https://t.co/lICd6Ptie4
@Reuters
Moderna CEO Bancel steps down as sales chief, Bloomberg News reports https://t.co/aJce1f2Avv https://t.co/gW1dwracxH
@Reuters
🇺🇸EARNINGS THIS WEEK:
• SUPER MICRO COMPUTER
• ARM HOLDINGS
• QUALCOMM
• ARISTA NETWORKS
• PALANTIR
• DATADOG
• FORTINET
• BLOCK
• DRAFTKINGS
• NOVO NORDISK
• MODERNA
• CVS HEALTH
• FERRARI
• TOYOTA
• LUCID MOTOR
• RIVIAN AUTOMOTIVE
• AIRBNB
• WYNN
• MARRIOTT… https://t.co/cE7U78GI7E https://t.co/qRewq75bos
@Investingcom
Northwestern sues Moderna for patent infringement over COVID-19 vaccines https://t.co/5Th5mOGMhB https://t.co/m7rsFkXU1P
@Reuters
Moderna slashes research spending, trims pipeline as it looks to regain footing
MarketWatch
Cathie Wood’s Ark ETFs buy a bunch of Moderna stock after record selloff
MarketWatch
⚠️BREAKING:
*MODERNA SHARES CLOSE 21% LOWER IN WORST ONE DAY DROP ON RECORD
$MRNA https://t.co/Bbv4PinSh4
@Investingcom
U.S. awards Moderna $176 million to produce bird flu vaccine - CNBC
CNBC
UK court gives mixed ruling in Pfizer v Moderna COVID vaccine patents case https://t.co/eCV2WLo1sb https://t.co/ant6wAXYMX
@Reuters
Moderna says new-generation COVID vaccine more effective than Spikevax for adults 18 and over
MarketWatch
3 actions extraordinary people take to achieve what seems impossible, from the co-founder of Moderna
CNBC
Moderna COVID/flu combo vaccine superior to separate shots in trial https://t.co/Q33aYRrR5V https://t.co/r9FaHl1xdA
@Reuters
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer - CNBC
CNBC
Moderna wins second approval with vaccine targeting RSV infection - Financial Times
Financial Times
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product - CNBC
CNBC
US nears deal to fund Moderna's bird flu vaccine trial, FT reports - Reuters
Reuters
Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot https://t.co/pu0pSdZbog https://t.co/gKLeO9j877
@Reuters
Moderna says FDA delayed RSV vaccine approval to end of May - CNBC
CNBC
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold - CNBC
CNBC
Moderna says new Covid vaccine showed stronger immune response than current shot in study
CNBC
5 stocks to watch on Thursday: Moderna, Enerplus on Chord Energy deal and more
SeekingAlpha
Moderna reports surprise profit, sets out road map for RSV vaccine https://t.co/Qh6vZXiMAZ https://t.co/OXzIwzoegq
@Reuters
Moderna posts surprise quarterly profit even as COVID sales continue to slide